IntelGenx Technologies Corp. is planning to raise funds via an equity offering that will be priced at a later date.
Each unit will consist of one common stock and half of a common share purchase warrant. Each whole warrant will allow the holder to buy one common share.
The offering will be conducted in the U.S and in the Canadian provinces of Alberta, British Columbia, Manitoba, Ontario and Quebec.
H.C. Wainwright & Co. is acting as the exclusive U.S. placement agent, while Echelon Wealth Partners Inc. is the exclusive placement agent for Canada.
Quebec-based IntelGenx Technologies develops and manufactures pharmaceutical oral films based on its proprietary VersaFilm technology platform.